leisure time -WSS

leisure time

author：knowledge 2025-08-24 04:06:39 - browse：68

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Why depression after traumatic brain injury is distinct

WSS

Amid AI frenzy, a top HHS official's quest to create safeguards

New report analyzes digital physical therapy solutions' effectiveness

Medical device trials still don't enroll enough women, study finds

Readout Newsletter: Bristol, Sangamo, Gilead, and more

ALS patient reclaims some autonomy thanks to wearable 'robot'

Why scientists need input from humanists on sensitive research

leisure time

leisure time

focus

Tori Bowie and the unacceptable rates of Black maternal death

Cigna wins case to block Amy Bricker's move to CVS

Supreme Court strikes down use of affirmative action

President Biden's budget: Here's what you might have missed

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why scientists need input from humanists on sensitive research

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pharma companies must ensure equitable access to obesity drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Steward Health Care Massachusetts hospitals face fiscal disaster

knowledge

'Essentially witchcraft:' A former naturopath takes on the field

STAT Virtual Event: ASCO Recap, Live!

Medical device trials still don't enroll enough women, study finds

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Statins may not be needed by millions of people, study suggests

Medical device trials still don't enroll enough women, study finds

explore

knowledge

knowledge

leisure time